10xBio Announces Data from Interim Analysis of Phase 2b Clinical Trial Showing Superior Efficacy of Novel Drug for Submental Body Contouring ...Middle East

The findings were presented in a late-breaking research abstract at the 2024 American Academy of Dermatology (AAD) Annual Meeting SAN DIEGO, March 11, 2024 /PRNewswire/ -- 10xBio, LLC, a biotechnology company that focuses on new uses for existing therapies and technologies, announced...

Hence then, the article about 10xbio announces data from interim analysis of phase 2b clinical trial showing superior efficacy of novel drug for submental body contouring was published today ( Monday 11/03/2024 - 06:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( 10xBio Announces Data from Interim Analysis of Phase 2b Clinical Trial Showing Superior Efficacy of Novel Drug for Submental Body Contouring )

Also on site :

• Top Indian Refiner Faces Profit Hit From Price Surge
• How to teach your children about money at different ages
• Manufacturing Category at 139th Canton Fair Presents Smarter, Lighter and More Connected Solutions